Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676306 · ClinicalTrials.gov registry record
Patient and Caregiver Priorities in Neuro-oncology Care
A clinical trial of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06676306: Recruiting study of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System, sponsored by Mayo Clinic.
NCT06676306 is a study of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 1,777-participant average among 3 other Malignant Central Nervous System Neoplasm trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06676306, a study of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.
Primary Outcome
Participant and caregiver interviews will be analyzed qualitatively and reported descriptively. Interviews will be analyzed to describe the patient experience related to primary or metastatic central nervous system (CNS) tumors.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-04-24 |
| Est. Completion | 2026-04-30 |
What NCT06676306 shows while recruiting
NCT06676306 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,777-participant average among 3 other Malignant Central Nervous System Neoplasm trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Malignant Central Nervous System Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06676306 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06676306 about?
NCT06676306 is a clinical study titled "Patient and Caregiver Priorities in Neuro-oncology Care". This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.
What is the current status of trial NCT06676306?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-04-24. Estimated completion is 2026-04-30.
What conditions does trial NCT06676306 study?
This clinical trial studies the following conditions: Malignant Central Nervous System Neoplasm, Metastatic Malignant Neoplasm in the Central Nervous System.
What interventions are being tested in trial NCT06676306?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06676306?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06676306 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Central Nervous System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
RECRUITING
-
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RECRUITING
-
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI